Shenzhen Hospital of Southern Medical University

Shenzhen Hospital of Southern Medical University represents Shenzhen's ambitious "Three Famous Projects" healthcare initiative in action — a newly built, government-funded academic medical center managed by one of China's oldest and most respected medical universities. Opened in December 2015, it is among China's youngest hospitals to achieve Grade A tertiary accreditation and has rapidly built distinctive strengths in digestive diseases, neuroscience, and 3D-printed orthopedic surgery.

History and Scale: The hospital was the first "famous hospital" project under Shenzhen's Three Famous Projects (名院·名科·名医) program — a multi-billion RMB initiative to rapidly upgrade the young city's healthcare infrastructure. The Shenzhen government provided the 82,412-square-meter site and construction funding in Bao'an District, while Southern Medical University (the former First Military Medical University of the PLA, founded 1951) contributes academic management, clinical protocols, and physician training. The hospital opened on December 28, 2015, with 1,100 Phase I beds in a facility designed for 8,000 daily outpatient visits. Phase II construction, launched in January 2023, will eventually bring total capacity to 2,500 beds across 490,000 square meters. By 2024, annual visits exceeded 1.6 million, and the hospital had grown to 48 clinical departments with over 2,000 staff. In 2022, it became the first hospital in Guangdong Province to achieve Grade A tertiary accreditation under the stringent 2020 revised standards.

Star Specialties: The Department of Gastroenterology is the hospital's flagship — a Shenzhen Municipal Key Medical Discipline with an affiliated municipal-level clinical research center for digestive diseases. It performs the full spectrum of advanced endoscopic procedures (ESD, POEM, ERCP) and runs one of China's most active fecal microbiota transplantation (FMT) programs, supported by a dedicated intestinal microecology research laboratory. The Neurology Department has built a high-volume ischemic stroke interventional program. The Orthopedics Department is a leader in digital and 3D-printed surgery, backed by a municipal key laboratory for digital surgery and 3D printing, producing patient-specific implants and surgical guides. Plastic Surgery & Burn Care, Nursing, and Traditional Chinese Medicine round out the hospital's Shenzhen-level key disciplines. The hospital also draws on Southern Medical University's 16 National Key Clinical Specialties — including nephrology, neurosurgery, cardiology, and obstetrics — with seven "Three Famous Teams" imported from SMU's Guangzhou mothership.

Achievements and Recognition: Beyond its record-setting fast track to Grade A tertiary accreditation (seven years from opening), the hospital was China's first to pass the new International Hospital Accreditation standards. It holds national-level chest pain center, stroke center, thrombosis prevention center, and upper GI bleeding emergency center designations. Since opening, it has secured 53 National Natural Science Foundation grants, published 457 SCI papers, obtained 275 patents, and accumulated over 100 million RMB in research funding — extraordinary productivity for a hospital barely a decade old. It maintains 48 postgraduate supervisors (17 doctoral) and operates six national standardized residency training bases.

International Services: The hospital's International Medical Service Center provides English-language care coordination, VIP outpatient and inpatient services, and direct billing with major international insurers. Its Bao'an District location places it near Shenzhen Bao'an International Airport and the Shenzhen-Zhongshan Bridge corridor, making it geographically accessible for cross-border patients. The gastroenterology and orthopedic 3D-printing programs are particularly equipped to serve international patients, with English-capable attending physicians and the ability to provide detailed treatment plans in English. The hospital's modern, Western-style management model — with its de-bureaucratized, performance-based employment system — creates a clinical culture that international patients will find more familiar than traditional Chinese public hospitals.

Why Choose SMU Shenzhen Hospital: For international patients seeking care at a modern, internationally accredited Chinese hospital unencumbered by the institutional inertia of older centers, this hospital's youth is genuinely an asset. Its gastroenterology program — combining expert interventional endoscopy with an active FMT program — is particularly compelling for patients with complex inflammatory bowel disease or refractory C. difficile infection. The 3D-printing orthopedic program offers customized implant solutions that may not be available in the patient's home country. And as a hospital born from military medical tradition (SMU's PLA heritage) and built to international standards, its operational discipline is exceptional.